207 related articles for article (PubMed ID: 26280898)
21. Synthesis, in vitro and in vivo activity of benzophenone-based inhibitors of steroid sulfatase.
Hejaz HA; Woo LW; Purohit A; Reed MJ; Potter BV
Bioorg Med Chem; 2004 May; 12(10):2759-72. PubMed ID: 15110857
[TBL] [Abstract][Full Text] [Related]
22. Design and synthesis of silicon-containing steroid sulfatase inhibitors possessing pro-estrogen antagonistic character.
Kajita D; Nakamura M; Matsumoto Y; Makishima M; Hashimoto Y
Bioorg Med Chem; 2014 Apr; 22(7):2244-52. PubMed ID: 24630694
[TBL] [Abstract][Full Text] [Related]
23. 6-(2-adamantan-2-ylidene-hydroxybenzoxazole)-O-sulfamate: a potent non-steroidal irreversible inhibitor of human steroid sulfatase.
Schreiner EP; Wolff B; Winiski AP; Billich A
Bioorg Med Chem Lett; 2003 Dec; 13(24):4313-6. PubMed ID: 14643316
[TBL] [Abstract][Full Text] [Related]
24. Phosphate and thiophosphate biphenyl analogs as steroid sulfatase inhibitors.
Demkowicz S; Kozak W; Daśko M; Masłyk M; Kubiński K; Rachon J
Drug Dev Res; 2015 Mar; 76(2):94-104. PubMed ID: 25845343
[TBL] [Abstract][Full Text] [Related]
25. 3Beta-sulfamate derivatives of C19 and C21 steroids bearing a t-butylbenzyl or a benzyl group: synthesis and evaluation as non-estrogenic and non-androgenic steroid sulfatase inhibitors.
Ciobanu LC; Boivin RP; Luu-The V; Poirier D
J Enzyme Inhib Med Chem; 2003 Feb; 18(1):15-26. PubMed ID: 12751816
[TBL] [Abstract][Full Text] [Related]
26. A new series of aryl sulfamate derivatives: Design, synthesis, and biological evaluation.
El-Gamal MI; Zaraei SO; Foster PA; Anbar HS; El-Gamal R; El-Awady R; Potter BVL
Bioorg Med Chem; 2020 Apr; 28(8):115406. PubMed ID: 32173116
[TBL] [Abstract][Full Text] [Related]
27. In vivo activity of 4-methylcoumarin-7-O-sulfamate, a nonsteroidal, nonestrogenic steroid sulfatase inhibitor.
Purohit A; Woo LW; Singh A; Winterborn CJ; Potter BV; Reed MJ
Cancer Res; 1996 Nov; 56(21):4950-5. PubMed ID: 8895749
[TBL] [Abstract][Full Text] [Related]
28. Dual aromatase-steroid sulfatase inhibitors.
Woo LW; Bubert C; Sutcliffe OB; Smith A; Chander SK; Mahon MF; Purohit A; Reed MJ; Potter BV
J Med Chem; 2007 Jul; 50(15):3540-60. PubMed ID: 17580845
[TBL] [Abstract][Full Text] [Related]
29. 17β-Arylsulfonamides of 17β-aminoestra-1,3,5(10)-trien-3-ol as highly potent inhibitors of steroid sulfatase.
Mostafa YA; Taylor SD
Bioorg Med Chem; 2012 Feb; 20(4):1535-44. PubMed ID: 22264754
[TBL] [Abstract][Full Text] [Related]
30. N-Acyl arylsulfonamides as novel, reversible inhibitors of human steroid sulfatase.
Lehr P; Billich A; Wolff B; Nussbaumer P
Bioorg Med Chem Lett; 2005 Feb; 15(4):1235-8. PubMed ID: 15686949
[TBL] [Abstract][Full Text] [Related]
31. Active site directed inhibition of estrone sulfatase by nonsteroidal coumarin sulfamates.
Woo LW; Purohit A; Reed MJ; Potter BV
J Med Chem; 1996 Mar; 39(7):1349-51. PubMed ID: 8691463
[No Abstract] [Full Text] [Related]
32. 2-Substituted 4-(thio)chromenone 6-O-sulfamates: potent inhibitors of human steroid sulfatase.
Nussbaumer P; Lehr P; Billich A
J Med Chem; 2002 Sep; 45(19):4310-20. PubMed ID: 12213072
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of steroid sulfatase activity and cell proliferation in ZR-75-1 and BT-474 human breast cancer cells by KW-2581 in vitro and in vivo.
Ishida H; Nakata T; Sato N; Li PK; Kuwabara T; Akinaga S
Breast Cancer Res Treat; 2007 Aug; 104(2):211-9. PubMed ID: 17061037
[TBL] [Abstract][Full Text] [Related]
34. Potent active site-directed inhibition of steroid sulphatase by tricyclic coumarin-based sulphamates.
Woo LL; Purohit A; Malini B; Reed MJ; Potter BV
Chem Biol; 2000 Oct; 7(10):773-91. PubMed ID: 11033081
[TBL] [Abstract][Full Text] [Related]
35. Discovery of a sulfamate-based steroid sulfatase inhibitor with intrinsic selective estrogen receptor modulator properties.
Ouellet C; Maltais R; Ouellet É; Barbeau X; Lagüe P; Poirier D
Eur J Med Chem; 2016 Aug; 119():169-82. PubMed ID: 27155470
[TBL] [Abstract][Full Text] [Related]
36. Design, structure-activity relationships, and enzyme kinetic studies of tricyclic and tetracyclic coumarin-based sulfamates as steroid sulfatase inhibitors.
Chiu PF; Lin IC; Lu YL; Chang CN; Chan HY; Lin TS; Tsai KC; Hsieh YSY; Chen MJ; Lin MH; Liang PH
Bioorg Chem; 2023 Sep; 138():106581. PubMed ID: 37172437
[TBL] [Abstract][Full Text] [Related]
37. Structure-activity relationships of 17alpha-derivatives of estradiol as inhibitors of steroid sulfatase.
Boivin RP; Luu-The V; Lachance R; Labrie F; Poirier D
J Med Chem; 2000 Nov; 43(23):4465-78. PubMed ID: 11087571
[TBL] [Abstract][Full Text] [Related]
38. A-ring substituted 17β-arylsulfonamides of 17β-aminoestra-1,3,5(10)-trien-3-ol as highly potent reversible inhibitors of steroid sulfatase.
Mostafa YA; Kralt B; Rao PP; Taylor SD
Bioorg Med Chem; 2015 Sep; 23(17):5681-92. PubMed ID: 26211459
[TBL] [Abstract][Full Text] [Related]
39. Synthesis of aromatase inhibitors and dual aromatase steroid sulfatase inhibitors by linking an arylsulfamate motif to 4-(4H-1,2,4-triazol-4-ylamino)benzonitrile: SAR, crystal structures, in vitro and in vivo activities.
Bubert C; Woo LW; Sutcliffe OB; Mahon MF; Chander SK; Purohit A; Reed MJ; Potter BV
ChemMedChem; 2008 Nov; 3(11):1708-30. PubMed ID: 18816537
[TBL] [Abstract][Full Text] [Related]
40. New fluorogenic substrate for the first continuous steroid sulfatase assay.
Bilban M; Billich A; Auer M; Nussbaumer P
Bioorg Med Chem Lett; 2000 May; 10(9):967-9. PubMed ID: 10853670
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]